Uncategorized
NovaBay Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market, reports financial results for the three and 12 months ended December 31, 2019 and provides a business update. “We exited 2019 with fourth quarter Avenova unit sales at their highest level of the year, with momentum being driven by consumer sales on Amazon.com,” said Justin Hall, President and CEO of NovaBay P